Automating drug discovery
暂无分享,去创建一个
[1] Andrew D Griffiths,et al. Synthesis of new hydrophilic rhodamine based enzymatic substrates compatible with droplet-based microfluidic assays. , 2017, Chemical communications.
[2] G. Roth,et al. Preparative microfluidic electrosynthesis of drug metabolites. , 2013, ACS medicinal chemistry letters.
[3] S. Satyanarayanajois,et al. Medicinal chemistry for 2020. , 2011, Future medicinal chemistry.
[4] Yair Glick,et al. DNA Bipedal Motor Achieves a Large Number of Steps Due to Operation Using Microfluidics-Based Interface. , 2017, ACS nano.
[5] Joost N. H. Reek,et al. Dynamic Combinatorial Chemistry in Chemical Catalysis , 2013 .
[6] David R. Spring,et al. Diversity-Oriented Synthesis: Producing Chemical Tools for Dissecting Biology , 2012 .
[7] Babur Hadimioglu,et al. Moving Liquids with Sound , 2016, Journal of laboratory automation.
[8] Stephen D. Roughley,et al. The Medicinal Chemist′s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates , 2011 .
[9] Raluca M. Fratila,et al. Small-volume nuclear magnetic resonance spectroscopy. , 2011, Annual review of analytical chemistry.
[10] Steven V Ley,et al. The use of a continuous flow-reactor employing a mixed hydrogen-liquid flow stream for the efficient reduction of imines to amines. , 2005, Chemical communications.
[11] Vijay S. Pande,et al. Low Data Drug Discovery with One-Shot Learning , 2016, ACS central science.
[12] G. Schneider,et al. Active learning for computational chemogenomics. , 2017, Future medicinal chemistry.
[13] Paulina Kanigowska,et al. Smart DNA Fabrication Using Sound Waves , 2016, Journal of laboratory automation.
[14] Roger D. Kamm,et al. Modeling the Blood-Brain Barrier in a 3D triple co-culture microfluidic system , 2015, 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).
[15] Gisbert Schneider,et al. Neural networks are useful tools for drug design , 2000, Neural Networks.
[16] Alexander G. Godfrey,et al. A remote-controlled adaptive medchem lab: an innovative approach to enable drug discovery in the 21st Century. , 2013, Drug discovery today.
[17] A V Eliseev,et al. Dynamic combinatorial chemistry: evolutionary formation and screening of molecular libraries. , 1999, Current topics in microbiology and immunology.
[18] David A. Patterson,et al. In-datacenter performance analysis of a tensor processing unit , 2017, 2017 ACM/IEEE 44th Annual International Symposium on Computer Architecture (ISCA).
[19] K. Baumann,et al. Chemoinformatic Classification Methods and their Applicability Domain , 2016, Molecular informatics.
[20] Sang-Hoon Lee,et al. Applications of micromixing technology. , 2010, The Analyst.
[21] Gisbert Schneider. De novo Molecular Design: Schneider/De novo Molecular Design , 2013 .
[22] Jing Li,et al. Representing high throughput expression profiles via perturbation barcodes reveals compound targets , 2016, PLoS Comput. Biol..
[23] Igor V Tetko,et al. A renaissance of neural networks in drug discovery , 2016, Expert opinion on drug discovery.
[24] A. Theberge,et al. Microdroplets in microfluidics: an evolving platform for discoveries in chemistry and biology. , 2010, Angewandte Chemie.
[25] Jordi Mestres,et al. Distant polypharmacology among MLP chemical probes. , 2015, ACS chemical biology.
[26] C. Oliver Kappe,et al. Process Intensified Flow Synthesis of 1H-4-Substituted Imidazoles: Toward the Continuous Production of Daclatasvir , 2015 .
[27] J Vidugiriene,et al. Miniaturized GPCR signaling studies in 1536-well format. , 2008, Journal of biomolecular techniques : JBT.
[28] Kimito Funatsu,et al. Exhaustive Structure Generation for Inverse‐QSPR/QSAR , 2010, Molecular informatics.
[29] G. Schneider,et al. Review : Macromolecular target prediction by self-organizing feature maps , 2016 .
[30] Vladimir Sykora,et al. Automation of decision making in drug design. , 2013, Drug discovery today. Technologies.
[31] Mickael Montembault,et al. Leveraging the Advantages Offered by Microfluidics to Enhance the Drug Discovery Process , 2005 .
[32] Kathrin Heikamp,et al. Do medicinal chemists learn from activity cliffs? A systematic evaluation of cliff progression in evolving compound data sets. , 2013, Journal of medicinal chemistry.
[33] A V Eliseev,et al. Dynamic Combinatorial Chemistry , 2001, Science.
[34] Pierre Baldi,et al. Learning to Predict Chemical Reactions , 2011, J. Chem. Inf. Model..
[35] Gisbert Schneider,et al. Steering target selectivity and potency by fragment-based de novo drug design. , 2013, Angewandte Chemie.
[36] Nathan Brown,et al. Multi-objective optimization methods in drug design. , 2013, Drug discovery today. Technologies.
[37] Richard C. Wilson,et al. Generative Models for Chemical Structures , 2010, J. Chem. Inf. Model..
[38] Dave Allen. Where will we get the next generation of medicinal chemists? , 2016, Drug discovery today.
[39] A. Vandenbroucke,et al. Technologies That Enable Accurate and Precise Nano- to Milliliter-Scale Liquid Dispensing of Aqueous Reagents Using Acoustic Droplet Ejection , 2016, Journal of laboratory automation.
[40] Meir Glick,et al. Extending 'predict first' to the design-make-test cycle in small-molecule drug discovery. , 2017, Future medicinal chemistry.
[41] Oliver J. Dressler,et al. Droplet-Based Microfluidics , 2014, Journal of biomolecular screening.
[42] Ross D. King,et al. Representation of probabilistic scientific knowledge , 2013, J. Biomed. Semant..
[43] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[44] G Schneider,et al. Artificial neural networks for computer-based molecular design. , 1998, Progress in biophysics and molecular biology.
[45] Klavs F Jensen,et al. An integrated microreactor system for self-optimization of a Heck reaction: from micro- to mesoscale flow systems. , 2010, Angewandte Chemie.
[46] Remo Hochstrasser,et al. Seamless integration of dose-response screening and flow chemistry: efficient generation of structure-activity relationship data of β-secretase (BACE1) inhibitors. , 2014, Angewandte Chemie.
[47] A. Gambin,et al. Predicting the outcomes of organic reactions via machine learning: are current descriptors sufficient? , 2017, Scientific Reports.
[48] Jun-ichi Yoshida,et al. Flash synthesis of TAC-101 and its analogues from 1,3,5-tribromobenzene using integrated flow microreactor systems , 2011 .
[49] Carsten Strohmann,et al. Total synthesis and absolute configuration of the guaiane sesquiterpene englerin A. , 2009, Angewandte Chemie.
[50] S. Quake,et al. Microfluidics: Fluid physics at the nanoliter scale , 2005 .
[51] Ulrike von Luxburg,et al. Feasibility of Active Machine Learning for Multiclass Compound Classification , 2016, J. Chem. Inf. Model..
[52] Peter Friess,et al. Internet of Things: Converging Technologies for Smart Environments and Integrated Ecosystems , 2013 .
[53] S. M. M. R. Al-Arif,et al. Deep learning for single-molecule science , 2017, Nanotechnology.
[54] Jeffrey Y. Pan,et al. An Integrated Synthesis-Purification System to Accelerate the Generation of Compounds in Pharmaceutical Discovery , 2011 .
[55] Andrew J. deMello,et al. Synthesis of Cesium Lead Halide Perovskite Nanocrystals in a Droplet-Based Microfluidic Platform: Fast Parametric Space Mapping. , 2016, Nano letters.
[56] Pierre Baldi,et al. No Electron Left Behind: A Rule-Based Expert System To Predict Chemical Reactions and Reaction Mechanisms , 2009, J. Chem. Inf. Model..
[57] Bram van Ginneken,et al. A survey on deep learning in medical image analysis , 2017, Medical Image Anal..
[58] Hayato Yoshida,et al. Continuous-flow synthesis of vitamin D3. , 2010, Chemical communications.
[59] P. H. Seeberger,et al. New Avenues to Efficient Chemical Synthesis , 2007 .
[60] R. M. Francis,et al. No Denying It: Medicinal Chemistry Training Is in Big Trouble. , 2016 .
[61] Petra Schneider,et al. From Complex Natural Products to Simple Synthetic Mimetics by Computational De Novo Design. , 2016, Angewandte Chemie.
[62] Knut Eis,et al. Automated medicinal chemistry. , 2006, Drug discovery today.
[63] P S Dittrich,et al. Implementing enzyme-linked immunosorbent assays on a microfluidic chip to quantify intracellular molecules in single cells. , 2013, Analytical chemistry.
[64] Ajay,et al. Recognizing molecules with drug-like properties. , 1999, Current opinion in chemical biology.
[65] Igor I. Baskin,et al. Stargate GTM: Bridging Descriptor and Activity Spaces , 2015, J. Chem. Inf. Model..
[66] Martin D. Burke,et al. Synthesis of many different types of organic small molecules using one automated process , 2015, Science.
[67] Antoine Cully,et al. Robots that can adapt like animals , 2014, Nature.
[68] Manju Bhaskar,et al. An overview on Combinatorial Chemistry , 2012 .
[69] Michael F Rafferty,et al. No Denying It: Medicinal Chemistry Training Is in Big Trouble. , 2016, Journal of medicinal chemistry.
[70] K. Lam,et al. Combinatorial chemistry in drug discovery. , 2017, Current opinion in chemical biology.
[71] Chang Lu,et al. A microfluidic device for epigenomic profiling using 100 cells , 2015, Nature Methods.
[72] Petra Schneider,et al. Privileged Structures Revisited , 2017, Angewandte Chemie.
[73] Ajay,et al. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? , 1998, Journal of medicinal chemistry.
[74] Antonio del Sol Mesa. Big-data-driven stem cell science and tissue engineering: vision and unique opportunities , 2017 .
[75] Qian Zhu,et al. Semantic inference using chemogenomics data for drug discovery , 2011, BMC Bioinformatics.
[76] Geoffrey E. Hinton,et al. Deep Learning , 2015, Nature.
[77] Daniel T. Chiu,et al. Chemistry and biology in femtoliter and picoliter volume droplets. , 2009, Accounts of chemical research.
[78] Sean Ekins. The Next Era: Deep Learning in Pharmaceutical Research , 2016, Pharmaceutical Research.
[79] Regina Barzilay,et al. Prediction of Organic Reaction Outcomes Using Machine Learning , 2017, ACS central science.
[80] Bradley J. Erickson,et al. Toolkits and Libraries for Deep Learning , 2017, Journal of Digital Imaging.
[81] Gisbert Schneider,et al. Identification of Hits and Lead Structure Candidates with Limited Resources by Adaptive Optimization , 2008, J. Chem. Inf. Model..
[82] Q. Fang,et al. Direct Surface and Droplet Microsampling for Electrospray Ionization Mass Spectrometry Analysis with an Integrated Dual-Probe Microfluidic Chip. , 2017, Analytical Chemistry.
[83] Christian Kramer,et al. Strong Nonadditivity as a Key Structure–Activity Relationship Feature: Distinguishing Structural Changes from Assay Artifacts , 2015, J. Chem. Inf. Model..
[84] B. Grzybowski,et al. Parallel optimization of synthetic pathways within the network of organic chemistry. , 2012, Angewandte Chemie.
[85] Aleksandra Baranczak,et al. Integrated Platform for Expedited Synthesis-Purification-Testing of Small Molecule Libraries. , 2017, ACS medicinal chemistry letters.
[86] Alexander K. Price,et al. An Integrated Microfluidic Processor for DNA-Encoded Combinatorial Library Functional Screening , 2017, ACS combinatorial science.
[87] Abhinav Vishnu,et al. Chemception: A Deep Neural Network with Minimal Chemistry Knowledge Matches the Performance of Expert-developed QSAR/QSPR Models , 2017, ArXiv.
[88] Andy Koswara,et al. Reaction screening and optimization of continuous-flow atropine synthesis by preparative electrospray mass spectrometry. , 2017, The Analyst.
[89] Johann Gasteiger,et al. Computer‐Assisted Planning of Organic Syntheses: The Second Generation of Programs , 1996 .
[90] Paul A. Wender,et al. Function through Synthesis-Informed Design , 2015, Accounts of chemical research.
[91] B. Munos. Lessons from 60 years of pharmaceutical innovation , 2009, Nature Reviews Drug Discovery.
[92] Dieter Lang,et al. Predicting drug metabolism: experiment and/or computation? , 2015, Nature Reviews Drug Discovery.
[93] Petra S Dittrich,et al. Advances in microfluidics for drug discovery , 2010, Expert opinion on drug discovery.
[94] Gisbert Schneider,et al. A Computational Method for Unveiling the Target Promiscuity of Pharmacologically Active Compounds. , 2017, Angewandte Chemie.
[95] Roland Zengerle,et al. Microfluidic platforms for lab-on-a-chip applications. , 2007, Lab on a chip.
[96] Lyn H. Jones,et al. Applications of chemogenomic library screening in drug discovery , 2017, Nature Reviews Drug Discovery.
[97] A. deMello,et al. Intelligent routes to the controlled synthesis of nanoparticles. , 2007, Lab on a chip.
[98] Sergey Plis,et al. Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data. , 2016, Molecular pharmaceutics.
[99] R. B. Merrifield. Solid phase peptide synthesis. I. the synthesis of a tetrapeptide , 1963 .
[100] Joshua Lederberg,et al. DENDRAL: A Case Study of the First Expert System for Scientific Hypothesis Formation , 1993, Artif. Intell..
[101] Milon Mondal,et al. Dynamic combinatorial chemistry: a tool to facilitate the identification of inhibitors for protein targets. , 2015, Chemical Society reviews.
[102] Mark Peplow,et al. Organic synthesis: The robo-chemist , 2014, Nature.
[103] Steve Edmondson,et al. 3D printed fluidics with embedded analytic functionality for automated reaction optimisation , 2017, Beilstein journal of organic chemistry.
[104] P. Leeson,et al. The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.
[105] Ryoji Kurita,et al. Microfluidic platforms for DNA methylation analysis. , 2016, Lab on a chip.
[106] Petra Schneider,et al. Combinatorial chemistry by ant colony optimization. , 2014, Future medicinal chemistry.
[107] S Y F Wong-Hawkes,et al. Microreactors as new tools for drug discovery and development. , 2006, Ernst Schering Foundation symposium proceedings.
[108] David R Spring,et al. Diversity-oriented synthesis: producing chemical tools for dissecting biology. , 2012, Chemical Society reviews.
[109] Gisbert Schneider,et al. Artificial neural networks and simulated molecular evolution are potential tools for sequence-oriented protein design , 1994, Comput. Appl. Biosci..
[110] G. Church,et al. Large-scale de novo DNA synthesis: technologies and applications , 2014, Nature Methods.
[111] Yoshihiro Yamanishi,et al. Benchmarking a Wide Range of Chemical Descriptors for Drug‐Target Interaction Prediction Using a Chemogenomic Approach , 2014, Molecular informatics.
[112] K. James,et al. Rapid access to compound libraries through flow technology: fully automated synthesis of a 3-aminoindolizine library via orthogonal diversification. , 2012, ACS combinatorial science.
[113] P. Seth,et al. The Medicinal Chemistry of Therapeutic Oligonucleotides. , 2016, Journal of medicinal chemistry.
[114] Bruno Botta,et al. The Pictet-Spengler Reaction Still on Stage. , 2016, Current pharmaceutical design.
[115] A. deMello,et al. 3D Droplet Microfluidic Systems for High-Throughput Biological Experimentation. , 2015, Analytical chemistry.
[116] James E. J. Mills,et al. Enhanced HTS Hit Selection via a Local Hit Rate Analysis , 2009, J. Chem. Inf. Model..
[117] D. Baker,et al. Emergence of a catalytic tetrad during evolution of a highly active artificial aldolase , 2016, Nature Chemistry.
[118] Michael Shevlin,et al. Practical High-Throughput Experimentation for Chemists , 2017, ACS medicinal chemistry letters.
[119] Cícero Nogueira dos Santos,et al. Boosting Docking-Based Virtual Screening with Deep Learning , 2016, J. Chem. Inf. Model..
[120] Satoshi Ichikawa,et al. Function-Oriented Synthesis: How to Design Simplified Analogues of Antibacterial Nucleoside Natural Products? , 2016, Chemical record.
[121] M. Maier,et al. Design and synthesis of analogues of natural products. , 2015, Organic & biomolecular chemistry.
[122] Hyeon-Eui Kim,et al. Deep mining heterogeneous networks of biomedical linked data to predict novel drug‐target associations , 2017, Bioinform..
[123] Luca Banfi,et al. Molecular Diversity and Combinatorial Chemistry , 2006, Molecular Diversity.
[124] Davide Castelvecchi,et al. Can we open the black box of AI? , 2016, Nature.
[125] Frank Glorius,et al. Contemporary screening approaches to reaction discovery and development. , 2014, Nature chemistry.
[126] Lars Carlsson,et al. ExCAPE-DB: an integrated large scale dataset facilitating Big Data analysis in chemogenomics , 2017, Journal of Cheminformatics.
[127] Elizabeth Farrant,et al. Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform. , 2013, Journal of medicinal chemistry.
[128] Hod Lipson,et al. Distilling Free-Form Natural Laws from Experimental Data , 2009, Science.
[129] David A Winkler,et al. Performance of Deep and Shallow Neural Networks, the Universal Approximation Theorem, Activity Cliffs, and QSAR , 2017, Molecular informatics.
[130] J. Zupan,et al. Neural networks: A new method for solving chemical problems or just a passing phase? , 1991 .
[131] Duncan Guthrie,et al. Continuous Flow-Processing of Organometallic Reagents Using an Advanced Peristaltic Pumping System and the Telescoped Flow Synthesis of (E/Z)-Tamoxifen , 2013 .
[132] Petra Schneider,et al. Accessing new chemical entities through microfluidic systems. , 2014, Angewandte Chemie.
[133] Jürgen Popp,et al. Making a big thing of a small cell--recent advances in single cell analysis. , 2014, The Analyst.
[134] Abhinav Vishnu,et al. Deep learning for computational chemistry , 2017, J. Comput. Chem..
[135] Kimito Funatsu,et al. Structure Modification toward Applicability Domain of a QSAR/QSPR Model Considering Activity/Property , 2017, Molecular informatics.
[136] H. Kubinyi,et al. A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.
[137] Zhi Zhu,et al. Hydrogel Droplet Microfluidics for High-Throughput Single Molecule/Cell Analysis. , 2017, Accounts of chemical research.
[138] G. V. Paolini,et al. Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.
[139] Gisbert Schneider,et al. Nonlinear dimensionality reduction and mapping of compound libraries for drug discovery. , 2012, Journal of molecular graphics & modelling.
[140] A. Gautam,et al. The changing model of big pharma: impact of key trends. , 2016, Drug discovery today.
[141] Charles W. Hutchins,et al. Current status and future prospects for enabling chemistry technology in the drug discovery process , 2016, F1000Research.
[142] Steven V Ley,et al. Accelerating spirocyclic polyketide synthesis using flow chemistry. , 2014, Angewandte Chemie.
[143] Y. S. Zhang,et al. Cancer-on-a-chip systems at the frontier of nanomedicine. , 2017, Drug discovery today.
[144] Helen Sneddon,et al. Embedding sustainable practices into pharmaceutical R&D: what are the challenges? , 2014, Future medicinal chemistry.
[145] Andreas Verras,et al. Is Multitask Deep Learning Practical for Pharma? , 2017, J. Chem. Inf. Model..
[146] Heike Schönherr,et al. Profound methyl effects in drug discovery and a call for new C-H methylation reactions. , 2013, Angewandte Chemie.
[147] Nicholas D. P. Cosford,et al. An integrated chemical biology approach reveals the mechanism of action of HIV replication inhibitors. , 2017, Bioorganic & medicinal chemistry.
[148] Kevin E Healy,et al. WAT-on-a-chip: a physiologically relevant microfluidic system incorporating white adipose tissue. , 2017, Lab on a chip.
[149] Angelo S. Mao,et al. 3D Printed Microtransporters: Compound Micromachines for Spatiotemporally Controlled Delivery of Therapeutic Agents , 2015, Advanced materials.
[150] Igor V. Tetko,et al. BIGCHEM: Challenges and Opportunities for Big Data Analysis in Chemistry , 2016, Molecular informatics.
[151] G. Schneider,et al. Peptide design by artificial neural networks and computer-based evolutionary search. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[152] Adam Nelson,et al. Embarking on a Chemical Space Odyssey. , 2017, Journal of medicinal chemistry.
[153] Paul D Leeson,et al. Molecular inflation, attrition and the rule of five. , 2016, Advanced drug delivery reviews.
[154] Charlotte Truchet,et al. Optimizing the Heck–Matsuda Reaction in Flow with a Constraint-Adapted Direct Search Algorithm , 2016 .
[155] Ryan L. Hartman,et al. Deciding Whether to Go with the Flow: Evaluating the Merits of Flow Reactors for Synthesis , 2011 .
[156] P Schneider,et al. Spotting and designing promiscuous ligands for drug discovery. , 2016, Chemical communications.
[157] Iskander Yusof,et al. Considering the impact drug-like properties have on the chance of success. , 2013, Drug discovery today.
[158] Lawrence G. Hamann,et al. Accessing Drug Metabolites via Transition‐Metal Catalyzed C—H Oxidation: The Liver as Synthetic Inspiration , 2016 .
[159] Steven V Ley,et al. Microwave reactions under continuous flow conditions. , 2007, Combinatorial chemistry & high throughput screening.
[160] Klavs F Jensen,et al. Feedback in Flow for Accelerated Reaction Development. , 2016, Accounts of chemical research.
[161] Stephen L. Crooks,et al. Overview of Combinatorial Chemistry , 2000, Current protocols in pharmacology.
[162] Petra Schneider,et al. Generative Recurrent Networks for De Novo Drug Design , 2017, Molecular informatics.
[163] D. H. Randle,et al. Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening? , 2015, Assay and drug development technologies.
[164] Alex Zhavoronkov,et al. Applications of Deep Learning in Biomedicine. , 2016, Molecular pharmaceutics.
[165] Tim Chapman. Lab automation and robotics: Automation on the move , 2003, Nature.
[166] Bradford A Pindzola,et al. Microstructured reactors as tools for the intensification of pharmaceutical reactions and processes. , 2009, Current opinion in drug discovery & development.
[167] Jun-ichi Yoshida,et al. Flash chemistry: fast chemical synthesis by using microreactors. , 2008, Chemistry.
[168] Hamza Landari,et al. Towards a Multifunctional Electrochemical Sensing and Niosome Generation Lab-on-Chip Platform Based on a Plug-and-Play Concept , 2016, Sensors.
[169] Marco Schorlemmer,et al. P2P proteomics -- data sharing for enhanced protein identification , 2012, Automated experimentation.
[170] A. Manz,et al. Lab-on-a-chip: microfluidics in drug discovery , 2006, Nature Reviews Drug Discovery.
[171] P Schneider,et al. Multi-objective active machine learning rapidly improves structure–activity models and reveals new protein–protein interaction inhibitors† †Electronic supplementary information (ESI) available: Details about computational comparisons and all screening results. See DOI: 10.1039/c5sc04272k , 2016, Chemical science.
[172] Chris Marshall,et al. Starting material oriented retrosynthetic analysis in the LHASA program. 3. Heuristic estimation of synthetic proximity , 1992, J. Chem. Inf. Comput. Sci..
[173] Gisbert Schneider,et al. De novo Drug Design – Ye olde Scoring Problem Revisited , 2017, Molecular informatics.
[174] Sung Jin Cho,et al. ADAAPT: Amgen's data access, analysis, and prediction tools , 2006, J. Comput. Aided Mol. Des..
[175] G. Schneider,et al. Enabling future drug discovery by de novo design , 2011 .
[176] Christoph Adami. Artificial intelligence: Robots with instincts , 2015, Nature.
[177] Orr Ravitz,et al. Data-driven computer aided synthesis design. , 2013, Drug discovery today. Technologies.
[178] Q. Fang,et al. Microfluidics for cell-based high throughput screening platforms - A review. , 2016, Analytica chimica acta.
[179] Ji-Bo Wang,et al. The Proximal Lilly Collection: Mapping, Exploring and Exploiting Feasible Chemical Space , 2016, J. Chem. Inf. Model..
[180] Martin D. Burke,et al. From Synthesis to Function via Iterative Assembly of N‐Methyliminodiacetic Acid Boronate Building Blocks , 2015 .
[181] O. A. Burmistrova,et al. Development of a Specific Substrate—Inhibitor Panel (Liver-on-a-Chip) for Evaluation of Cytochrome P450 Activity , 2016, Bulletin of Experimental Biology and Medicine.
[182] Lei Xie,et al. Harnessing Big Data for Systems Pharmacology , 2016, bioRxiv.
[183] Jose M. Palomo,et al. Solid-phase peptide synthesis: an overview focused on the preparation of biologically relevant peptides , 2014 .
[184] E. Corey. General methods for the construction of complex molecules , 1967 .
[185] Katharine Sanderson. March of the synthesis machines , 2015, Nature Reviews Drug Discovery.
[186] Emile M. Bellott,et al. Combinatorial Chemistry in the Drug Discovery Process , 1997 .
[187] Klavs F Jensen,et al. "Batch" kinetics in flow: online IR analysis and continuous control. , 2013, Angewandte Chemie.
[188] Jonas Boström,et al. Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone? , 2016, Journal of medicinal chemistry.
[189] Herbert Waldmann,et al. Principles, implementation, and application of biology-oriented synthesis (BIOS) , 2010, Biological chemistry.
[190] Peter H. Seeberger,et al. Synthesis and medical applications of oligosaccharides , 2007, Nature.
[191] Rohit Rana,et al. An eco-compatible strategy for the diversity-oriented synthesis of macrocycles exploiting carbohydrate-derived building blocks , 2017, Beilstein journal of organic chemistry.
[192] G. Schneider,et al. Combining on-chip synthesis of a focused combinatorial library with computational target prediction reveals imidazopyridine GPCR ligands. , 2014, Angewandte Chemie.
[193] Maria F. Sassano,et al. Automated design of ligands to polypharmacological profiles , 2012, Nature.
[194] Richard J Ingham,et al. Organic synthesis: march of the machines. , 2015, Angewandte Chemie.
[195] Martin Stahl,et al. Rationalizing Tight Ligand Binding through Cooperative Interaction Networks , 2011, J. Chem. Inf. Model..
[196] Wyeth W. Wasserman,et al. Deep Feature Selection: Theory and Application to Identify Enhancers and Promoters , 2015, RECOMB.
[197] Gisbert Schneider,et al. Multidimensional de novo design reveals 5-HT2B receptor-selective ligands. , 2015, Angewandte Chemie.
[198] Steven V. Ley,et al. Flow Chemistry: Intelligent Processing of Gas-Liquid Transformations Using a Tube-in-Tube Reactor , 2015 .
[199] S. Schreiber,et al. Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.
[200] Gisbert Schneider. De novo Molecular Design , 2013 .
[201] Steven V Ley,et al. A flow-based synthesis of imatinib: the API of Gleevec. , 2010, Chemical communications.
[202] Gisbert Schneider,et al. Computer-based de novo design of drug-like molecules , 2005, Nature Reviews Drug Discovery.
[203] Igor V Tetko,et al. Does 'Big Data' exist in medicinal chemistry, and if so, how can it be harnessed? , 2016, Future medicinal chemistry.
[204] João Rodrigues,et al. Why and how have drug discovery strategies in pharma changed? What are the new mindsets? , 2016, Drug discovery today.
[205] S. Y. Wong,et al. On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system , 2016, Science.
[206] Anna Goldenberg,et al. TensorFlow: Biology's Gateway to Deep Learning? , 2016, Cell systems.
[207] Glenn P Carroll,et al. Measuring the effectiveness and impact of an open innovation platform. , 2017, Drug discovery today.
[208] Brian H Warrington,et al. Automated flow-through synthesis of heterocyclic thioethers. , 2004, Journal of combinatorial chemistry.
[209] Lu Zhang,et al. From machine learning to deep learning: progress in machine intelligence for rational drug discovery. , 2017, Drug discovery today.
[210] Jun-ichi Yoshida,et al. Flash chemistry: flow chemistry that cannot be done in batch. , 2013, Chemical communications.
[211] Brian H Warrington,et al. Synthesis of a three-member array of cycloadducts in a glass microchip under pressure driven flow. , 2002, Lab on a chip.
[212] J. Scannell,et al. Diagnosing the decline in pharmaceutical R&D efficiency , 2012, Nature Reviews Drug Discovery.
[213] Petra Schneider,et al. De Novo Design at the Edge of Chaos. , 2016, Journal of medicinal chemistry.
[214] Ross D King,et al. Intelligent software for laboratory automation. , 2004, Trends in biotechnology.
[215] Steven V Ley,et al. Flow chemistry syntheses of natural products. , 2013, Chemical Society reviews.
[216] R. J. Beulig,et al. A droplet-chip/mass spectrometry approach to study organic synthesis at nanoliter scale. , 2017, Lab on a chip.
[217] Junbo Wang,et al. Development of Droplet Microfluidics Enabling High-Throughput Single-Cell Analysis , 2016, Molecules.
[218] A. Long,et al. Parallel Chemistry in the 21st Century , 2012, Current protocols in pharmacology.
[219] Mitsutoshi Nakajima,et al. Recent lab‐on‐chip developments for novel drug discovery , 2017, Wiley interdisciplinary reviews. Systems biology and medicine.
[220] Koushik Mondal. Design Issues of Big Data Parallelisms , 2016 .
[221] Petra Schneider,et al. Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus , 2014, Proceedings of the National Academy of Sciences.
[222] Lawrence B. Holder,et al. Machine learning for epigenetics and future medical applications , 2017, Epigenetics.
[223] Elizabeth Farrant,et al. Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug Discovery. , 2013, ACS medicinal chemistry letters.
[224] Piotr Dittwald,et al. Computer-Assisted Synthetic Planning: The End of the Beginning , 2016 .
[225] Paul A Wender,et al. Function-oriented synthesis, step economy, and drug design. , 2008, Accounts of chemical research.
[226] Anthony P. F. Cook,et al. Computer‐aided synthesis design: 40 years on , 2012 .
[227] D. Chiu,et al. Selective encapsulation of single cells and subcellular organelles into picoliter- and femtoliter-volume droplets. , 2005, Analytical chemistry.
[228] Amine Miled,et al. Electrochemical imaging for microfluidics: a full-system approach. , 2016, Lab on a chip.
[229] Wolfgang Guba,et al. Neighborhood-preserving visualization of adaptive structure-activity landscapes: application to drug discovery. , 2011, Angewandte Chemie.
[230] Jeremy L. Steinbacher,et al. Simplified Mesofluidic Systems for the Formation of Micron to Millimeter Droplets and the Synthesis of Materials , 2012, Journal of Flow Chemistry.
[231] Gisbert Schneider,et al. Flashback Forward: Reaction-Driven de novo Design of Bioactive Compounds , 2014 .
[232] Johann Gasteiger. Physicochemical effects in the representation of molecular structures for drug designing. , 2003, Mini reviews in medicinal chemistry.
[233] Hiromasa Kaneko,et al. Inverse QSPR/QSAR Analysis for Chemical Structure Generation (from y to x) , 2016, J. Chem. Inf. Model..
[234] Yanju Wang,et al. An integrated microfluidic device for large-scale in situ click chemistry screening. , 2009, Lab on a chip.
[235] Eduardo Garcia-Egido,et al. Synthesis and analysis of combinatorial libraries performed in an automated micro reactor system. , 2003, Lab on a chip.
[236] Petra Schneider,et al. Multi-objective molecular de novo design by adaptive fragment prioritization. , 2014, Angewandte Chemie.
[237] David Ryan Koes,et al. Protein-Ligand Scoring with Convolutional Neural Networks , 2016, Journal of chemical information and modeling.
[238] Shuigeng Zhou,et al. Boosting compound-protein interaction prediction by deep learning , 2015, BIBM.
[239] T. LaPorte,et al. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients. , 2007, Current opinion in drug discovery & development.
[240] Gisbert Schneider,et al. Flashback Forward: Reaction-Driven De Novo Design of Bioactive Compounds , 2013 .
[241] A. Bogdan,et al. Enabling Chemistry Technologies and Parallel Synthesis-Accelerators of Drug Discovery Programmes. , 2017, Progress in medicinal chemistry.
[242] Gisbert Schneider,et al. Active-learning strategies in computer-assisted drug discovery. , 2015, Drug discovery today.
[243] D. Huh,et al. Organs-on-chips at the frontiers of drug discovery , 2015, Nature Reviews Drug Discovery.
[244] Anthony Atala,et al. Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling. , 2016, Drug discovery today.
[245] Stefan Wetzel,et al. Biology-oriented synthesis. , 2011, Angewandte Chemie.
[246] Maria Liakata,et al. Towards Robot Scientists for autonomous scientific discovery , 2010, Automated experimentation.
[247] David Li,et al. Deep Learning in Drug Discovery and Medicine; Scratching the Surface , 2018, Molecules.
[248] Steven V Ley,et al. Flow chemistry: intelligent processing of gas-liquid transformations using a tube-in-tube reactor. , 2015, Accounts of chemical research.
[249] Kento Ishida,et al. Total Synthesis of (±)-Englerin A Using An Intermolecular [3+2] Cycloaddition Reaction of Platinum-Containing Carbonyl Ylide. , 2016, Chemistry, an Asian journal.
[250] A. Abate,et al. Ultrahigh-throughput screening in drop-based microfluidics for directed evolution , 2010, Proceedings of the National Academy of Sciences.
[251] Ken E. Whelan,et al. The Automation of Science , 2009, Science.
[252] Petra Schneider,et al. De Novo Fragment Design for Drug Discovery and Chemical Biology. , 2015, Angewandte Chemie.
[253] Jeremiah P. Malerich,et al. Multi-step continuous flow synthesis of fluconazole , 2018, Journal of Flow Chemistry.